![]() |
![]() |
![]() |
![]() |
![]() |
Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Brut.. | Li Wang | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Persistence of Monotypic Plasma Cells after Chemoimmunotherapy in Patients with Waldenstroem Macrogl.. | Marzia Varettoni | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Impact of Bone Marrow Evaluation Using Bone Marrow Biopsy, Flow Cytometry, and PET/CT in B-Cell Non-.. | José Antonio Sánchez Salas | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Second Primary Malignancies in Marginal Zone Lymphoma Survivors | Kriti Ahuja | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impa.. | Ana Marin Niebla | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
A Phase II Trial of Loncastuximab Tesirine in Patients with Previously Treated Waldenstroem Macroglo.. | Shayna R Sarosiek | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Coho.. | Ingrid Glimelius | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Ly.. | Jie Wang | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/.. | Mazyar Shadman | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Preliminary Efficacy and Safety of a Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab .. | Austin I. Kim | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Long-Term Follow-up of Bendamustine/Rituximab – Rituximab/Cytarabine (BR/RC) Induction Therapy for P.. | Christine Ryan | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Obinutuzumab, Lenalidomide and Venetoclax for the Initial Treatment of Patients with Advanced-Stage .. | Chan Y. Cheah | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): R.. | Elizabeth Brem | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change .. | Judith Trotman | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Importance of Access Inequality and Biological Prognostic Factors in Mantle Cell Lymphoma Outcomes i.. | Rony Schaffel | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High.. | David Russler-Germain | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
A Phase I/II Study of Tazemetostat Combined with Abbreviated Rituximab/Bendamustine Therapy for High.. | Vaishalee P Kenkre | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Au.. | Joshua Tobin | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd | Lu Zhang | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
![]() |
Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymp.. | Liang Wang | 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell.. |
Thunderstorm-related asthma in patients sensitised to olea europaea pollen: twenty emergency department visits for asthmatic symptoms in one single day Losappio, Laura1; Heffler, Enrico2; Falco, Antonio1; Contento, Francesco1; Cannito, Cosimo1; Rolla, Giovanni2 1"Dimiccoli" Hospital, Emergency Department, Barletta, Italy; 2University of Torino - AO Mauriziano "Umberto I", Allergy and Clinical Immunology, Torino, Italy
Background: Associations between thunderstorm and asthma morbidity have been reported in several countries. Common to all epidemics of thunderstorm-related asthma is a significant increase in atmospheric allergen load during and immediately after a thunderstorm. Sensitization to Alternaria species or to grass and parietaria pollens has been suggested to play a key role in thunderstorm-related asthma. The only reported event of thunderstorm-related asthma in Mediterranean area was attributed to sensitization to parietaria pollen.
Method: here we describe a series of 20 patients who presented to Emergency Department in Barletta (94,000 inhabitants), Puglia (Italy) for sudden and severe asthmatic symptoms between May 27th and 28th 2010 (from15:36 to 5:02), immediately after a violent thunderstorm which occurred following a very hot morning (mean temperature: 29°C). All the patients have been subsequently visited by an allergist and underwent allergological work-up which included skin prick tests and a careful clinical history. Local pollen counts were available.
Result: Between May 10th and June 10th 2010, 86 Emergency Department asthma visits were recorded, 20 of them during the study day. Patients' mean age was 44.25 +/- 18.5 years (range: 9-81), 8/20 females, 2 smokers, 16 with a previous history of known respiratory allergy. Only two patients regularly took anti-asthma drugs. All 20 patients were sensitized to Olea europaea pollen, 7 of whom were monosensitized. Ten patients were sensitized to grass, 7 to parietaria, 5 to compositae, 5 to cypress, 5 to house dust mites, 3 to dog and 1 to cat danders. No patient was sensitized to Alternaria. Mean pollen count was 17 granules/m3 for Olea europaea, 6 granules/m3 for grass pollen.
Conclusion: This is, in our knowledge, the second epidemic of thunderstorm related asthma described in Mediterranean area and the first one in which sensitization to Olea europaea played a key-role. In conclusion, our report indicates that thunderstorm asthma may involve different allergens (not only fungal spores and grass or parietaria pollen) in different geographic areas, depending on the seasonality of thunderstorms and allergenic pollen.